Clinical Trials · NCT07424430
Real-world Canadian Retrospective Study Evaluating Longitudinal Semaglutide Use on Cardio-Kidney-Metabolic Outcomes
- Phase
- N/A
- Recruitment status
- Not Yet Recruiting
- Sponsor
- LMC Diabetes & Endocrinology Ltd.
- Enrollment
- 400
- Start date
- Mar 2026
- Locations
- See registry
- Primary endpoint
- Change in HbA1c- 3 Years